| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 32.188 | 45.729 | 48.134 | 50.697 | 56.368 | 62.903 | 70.204 |
| Total Income - EUR | - | - | - | 32.192 | 45.739 | 50.212 | 50.704 | 56.384 | 62.904 | 70.207 |
| Total Expenses - EUR | - | - | - | 12.651 | 16.134 | 19.557 | 17.836 | 18.429 | 24.130 | 26.672 |
| Gross Profit/Loss - EUR | - | - | - | 19.541 | 29.605 | 30.655 | 32.868 | 37.954 | 38.774 | 43.534 |
| Net Profit/Loss - EUR | - | - | - | 19.219 | 29.147 | 30.210 | 32.361 | 37.402 | 38.221 | 41.470 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Cabinet Dr. Poalelungi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 23.137 | 43.575 | 53.037 | 33.498 | 38.073 | 48.114 | 43.707 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 5.422 |
| Receivables | - | - | - | 4.236 | 648 | 579 | 947 | 32.090 | 9.927 | 0 |
| Cash | - | - | - | 18.900 | 42.927 | 52.458 | 32.551 | 5.983 | 38.186 | 38.285 |
| Shareholders Funds | - | - | - | 19.262 | 42.682 | 52.334 | 32.409 | 37.450 | 47.524 | 41.518 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.875 | 913 | 741 | 1.173 | 665 | 641 | 2.188 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Dr. Poalelungi Srl